Zobrazeno 1 - 3
of 3
pro vyhledávání: '"David Atomanyi Barnes"'
Autor:
Sadiq Mohammed Damina, David Atomanyi Barnes, Bitrus Inuwa, Gulak Hussaini Ularamu, Mohammed Bello, Olu Solomon Okaiyeto, Ayuba Caleb Kudi, Jeewan Thapa, Chie Nakajima, Yasuhiko Suzuki
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 7, Pp 6055-6066 (2023)
Bovine tuberculosis is endemic in Nigeria with control measures as provided by the laws of the country being minimally enforced mostly at the abattoirs only. This study focused on bovine tuberculosis in Adamawa and Gombe States. Tuberculosis lesions
Externí odkaz:
https://doaj.org/article/db9a775b4c0649bba8159c9a63c8c4eb
Autor:
Joseph Yamweka Chizimu, Eddie Samuneti Solo, Precious Bwalya, Thoko Flav Kapalamula, Kaemba Kunkuta Mwale, David Squarre, Misheck Shawa, Patrick Lungu, David Atomanyi Barnes, Kaunda Yamba, Tiza Mufune, Herman Chambaro, Harvey Kamboyi, Musso Munyeme, Bernard Mudenda Hang’ombe, Nathan Kapata, Victor Mukonka, Roma Chilengi, Jeewan Thapa, Chie Nakajima, Yasuhiko Suzuki
Publikováno v:
Antibiotics, Vol 12, Iss 7, p 1126 (2023)
The emergence of pre-extensively drug-resistant tuberculosis (pre-XDR-TB) is a threat to TB control programs in developing countries such as Zambia. Studies in Zambia have applied molecular techniques to understand drug-resistance-associated mutation
Externí odkaz:
https://doaj.org/article/5fe6dd4cfbbb4f3cb1adb747afffd820
Autor:
Suzuki, Joseph Yamweka Chizimu, Eddie Samuneti Solo, Precious Bwalya, Thoko Flav Kapalamula, Kaemba Kunkuta Mwale, David Squarre, Misheck Shawa, Patrick Lungu, David Atomanyi Barnes, Kaunda Yamba, Tiza Mufune, Herman Chambaro, Harvey Kamboyi, Musso Munyeme, Bernard Mudenda Hang’ombe, Nathan Kapata, Victor Mukonka, Roma Chilengi, Jeewan Thapa, Chie Nakajima, Yasuhiko
Publikováno v:
Antibiotics; Volume 12; Issue 7; Pages: 1126
The emergence of pre-extensively drug-resistant tuberculosis (pre-XDR-TB) is a threat to TB control programs in developing countries such as Zambia. Studies in Zambia have applied molecular techniques to understand drug-resistance-associated mutation